Waldencast plc Class A Ordinary Share (WALD) is a publicly traded Technology sector company. As of May 21, 2026, WALD trades at $1.31 with a market cap of $200.09M and a P/E ratio of 0.00. WALD moved +0.00% today. Year to date, WALD is -19.14%; over the trailing twelve months it is -39.91%. Its 52-week range spans $0.72 to $4.18. Analyst consensus is buy with an average price target of $2.17. Rallies surfaces WALD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Obagi Medical’s Real-World Data Shows 94% Injector Approval for MagIQ Filler: Obagi Medical’s interim ALOHA program data shows 94% of over 300 injectors endorse its Saypha® MagIQ filler and 43% of patients also evaluating Obagi skincare. A 12-week open-label study demonstrated NU-GEN™ Cellular Renewal Serum can reverse skin age by up to six years, improving wrinkles, hyperpigmentation and firmness.
| Metric | Value |
|---|---|
| Price | $1.31 |
| Market Cap | $200.09M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.18 |
| 52-Week Low | $0.72 |
| Volume | 1.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.43M |
| Gross Margin | 0.00% |
3 analysts cover WALD: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.17.